DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Campath (Alemtuzumab) - Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Infection (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Campath side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Phlebitis, Hydronephrosis, Adenovirus Infection, Cystitis Haemorrhagic, Human Polyomavirus Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Folic Acid; Bactrim; Vfend; Valganciclovir



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Cystitis Haemorrhagic, Adenovirus Infection, Human Polyomavirus Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Vfend; Bactrim; Valganciclovir; Folic Acid



Possible Campath side effects in female

Reported by a lawyer from United States on 2012-07-20

Patient: female

Reactions: Abdominal Pain, Upper Limb Fracture, Vulval Ulceration, Face Oedema, Upper Respiratory Tract Infection, Phlebolith, Hypotension, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Chest Pain, Bone Disorder, Depression, Bundle Branch Block Left, Discomfort, Impaired Healing, Sepsis, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Hypocalcaemia, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Stomatitis, Pneumonia, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Confusional State, Atelectasis, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Sinusitis, Hallucination, Venous Lake, RIB Fracture, Pain in JAW, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Osteolysis, Rash, Deformity, Facial Pain, Pulmonary Fibrosis, Anxiety, Mucosal Inflammation, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, qmo
    Indication: Multiple Myeloma

Campath
    End date: 2004-09-27

Thalidomide

Other drugs received by patient: Mevacor; COD-Liver OIL; Multivite; Acyclovir; Neurontin; Peridex; Scopolamine; Darvocet-N 50; Tylenol; Magnesium Sulfate; Prednisone TAB; Aspirin; Hydralazine HCL; Calcium; Lovastatin; Ativan; Chemotherapeutics NOS; Procrit / 00909301 /; MS Contin; Solu-Medrol; Augmentin '125'; Revlimid



Possible Campath side effects in female

Reported by a lawyer from United States on 2012-04-18

Patient: female

Reactions: Abdominal Pain, Vulval Ulceration, Upper Limb Fracture, Face Oedema, Hypotension, Phlebolith, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Depression, Bone Disorder, Discomfort, Impaired Healing, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Pneumonia, Stomatitis, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Atelectasis, Confusional State, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Hallucination, Sinusitis, Venous Lake, Pain in JAW, RIB Fracture, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Rash, Osteolysis, Deformity, Facial Pain, Pulmonary Fibrosis, Mucosal Inflammation, Anxiety, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aredia
    Dosage: unk ukn, qmo
    Indication: Multiple Myeloma

Campath
    Dosage: unk
    End date: 2004-09-27

Thalidomide

Other drugs received by patient: Darvocet-N 50; Magnesium; Aspirin; Augmentin '125'; Revlimid; Ativan; Calcium Carbonate; Hydralazine HCL; Prednisone TAB; COD-Liver OIL; Tylenol (Caplet); Chemotherapeutics NOS; Procrit / 00909301 /; Solu-Medrol; Lovastatin; Acyclovir; Neurontin; Peridex; MS Contin; Multivite; Mevacor; Scopolamine



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-21

Patient: male, weighing 69.2 kg (152.2 pounds)

Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    End date: 2011-10-07

Campath
    Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-07-24

Dexamethasone
    Dosage: 40 mg, qd 1-4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27

Dexamethasone
    Dosage: 40 mg, qd 15-18
    Administration route: Oral
    End date: 2011-10-03

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acetaminophen; Valaciclovir; Clemastine Fumarate



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-30

Patient: male, weighing 69.2 kg (152.2 pounds)

Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    End date: 2011-10-07

Campath
    Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-07-24

Dexamethasone
    Dosage: 40 mg, qd 1-4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27

Dexamethasone
    Dosage: 40 mg, qd 15-18
    Administration route: Oral
    End date: 2011-10-03

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Cotrim; Valaciclovir; Paracetamol



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: C-Reactive Protein Increased, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-07

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-06

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Acetaminophen; Cotrim; Valaciclovir



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-02

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: C-Reactive Protein Increased, Pneumonia Bacterial, Chills, Febrile Neutropenia, Troponin Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd on days 1, 3 and 5
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-21
    End date: 2011-08-12

Campath
    Dosage: 30 mg, qd on days 1, 3 and 5
    Start date: 2011-08-29
    End date: 2011-09-12

Dexamethasone
    Dosage: 40 mg, qdx4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-09-02
    End date: 2011-09-05

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-09-02

Other drugs received by patient: Candesartan Cilexetil; Simvastatin; Nebivolol HCL; Marcumar; Pantoprazole; Novalgin; Pentacarinat; Tamsulosin HCL



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: C-Reactive Protein Increased, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-07

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-06

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Pantoprazole Sodium; Valaciclovir; Clemastine Fumarate; Cotrim; Acetaminophen



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-26

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia Bacterial, C-Reactive Protein Increased, Chills, Febrile Neutropenia, Troponin Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-21
    End date: 2011-08-12

Dexamethasone
    Dosage: 40 mg, qdx4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-09-02
    End date: 2011-09-05

Narcumar
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-09-02

Other drugs received by patient: Novalgin; Pantoprazole; Tamsulosin HCL; Pentacarinat; Nebivolol HCL; Simvastin-Mepha



Possible Campath side effects in female

Reported by a physician from Belgium on 2011-10-17

Patient: female, weighing 37.4 kg (82.3 pounds)

Reactions: Pneumonia, Arthralgia, General Physical Health Deterioration, Decreased Appetite, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Voltaren; Acetaminophen; Tribvic; Xalatan; Laxoberon; D-Cure; Minoxidil; Oxycontin; Climen; Androcur; Deanxit; Oxycontin; Oxycontin; Calcium Sandoz; Morphine; Omeprazole; Artcoptic; Atroptic; Redomex; Dapsone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017